In re Plasma-Derivative Protein Therapies Antitrust Litigation
Oct 08, 2013OUTCOME: $46 million settlement
Represented several large non-profit hospitals for damages they suffered as a result of an alleged antitrust conspiracy to limit the supply of life saving plasma-derivative protein therapies.
